Company INSTITUT Moscow Micex - RTS

Equities

ISKJ

RU000A0JNAB6

Healthcare Facilities & Services

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Company contact information

Sector

Sales per Business

Sector Other Healthcare Facilities & Services

Inactive Instrument

End-of-day quote Moscow Micex - RTS Other stock markets
- ^USD	-

04-26	Artgen Biotech PJSC Reports Earnings Results for the Full Year Ended December 31, 2023	CI
2023	Artgen Biotech PJSC Reports Earnings Results for the Half Year Ended June 30, 2023	CI

Institut Stvolovykh Kletok Cheloveka PAO (Human Stem Cells Institute OJSC or HSCI OJSC) is a Russia-based company engaged in the research and development, as well as commercialization and marketing of proprietary products and services in the areas of cell-based and gene and post-genome technologies. The Company is engaged in such projects as: Gemabank, cord blood stem cells bank; Gemascreen medical genetic diagnostics and consulting services provided by the Company domestically with the aim of early detection, treatment or prevention of inherited diseases; SPRS-therapy service a set of personalized diagnostics and treatment procedures; SynBio, which focuses on development of new medicines. In addition, the Company is a producer of Neovasculgen, a gene-therapy drug. In February 2014, it opened a biotech complex in Kyiv.

RUB in Million	2021	Weight	2022	Weight	Delta
Neovasculgen 27.5 %	186	15.8 %	313	27.5 %	+68.21%
Genetiko 25.1 %	384	32.5 %	285	25.1 %	-25.58%
Gemabank 22.6 %	267	22.6 %	257	22.6 %	-3.70%
Reprobank 17.8 %	283	24.0 %	202	17.8 %	-28.67%
SPRS-Therapy 4.8 %	54	4.6 %	54	4.8 %	-0.33%
Other Areas and Unallocated Business Expenses 2.2 %	7	0.6 %	25	2.2 %	+285.36%

RUB in Million	2021	Weight	2022	Weight	Delta
Russia 100.0 %	1,181	100.0 %	1,137	100.0 %	-3.72%

Managers	Title	Age	Since
Artur Alexandrovich Isaev FOU	Founder	54	26/11/03
Olga Viktorovna Sidorova DFI	Director of Finance/CFO	-	-
Tatiana Valeryevna Tiutiunnikova ADM	Chief Administrative Officer	-	-
Roman Deev CTO	Chief Tech/Sci/R&D Officer	45	31/01/10
Igor Viktorovich Chernykh BRD	Director/Board Member	-	-
Sergey Kiselev BRD	Director/Board Member	66	27/06/07
Alexander Prikhodko BRD	Director/Board Member	65	04/01/04
Svetlana Vladimirovna Samoylova IRC	Investor Relations Contact	56	28/07/10
Svetlana Viktorovna Blokhina AUD	Comptroller/Controller/Auditor	-	-
Natalia Vladimirovna Derevyannykh HRO	Human Resources Officer	-	-

Members of the board	Title	Age	Since
Andrey Isaev BRD	Director/Board Member	53	27/06/07
Alexander Prikhodko BRD	Director/Board Member	65	04/01/04
Sergey Kiselev BRD	Director/Board Member	66	27/06/07
Roman Deev CTO	Chief Tech/Sci/R&D Officer	45	31/01/10
Dmitry Aleksandrov BRD	Director/Board Member	43	31/12/10
Artur Alexandrovich Isaev FOU	Founder	54	26/11/03
Konstantin Nikolayevich Mauer BRD	Director/Board Member	-	03/03/16
Vyacheslav Shulenin BRD	Director/Board Member	-	28/06/23
Dmitry Boguslavsky BRD	Director/Board Member	-	28/06/23
Alexey Primak BRD	Director/Board Member	-	28/06/23

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	92,645,451	21,091,099 ( 22.77 %)	17,496,535 ( 18.89 %)	22.77 %

Artgen Biotech PJSC

18/1, Olimpiyskiy Avenue

129110, Moscow

http://www.hsci.ru

Healthcare

Healthcare Services

Healthcare Providers & Services

Healthcare Facilities & Services

Other Healthcare Facilities & Services

	1st Jan change	Capi.
HCA HEALTHCARE, INC.	+18.41%	83.07B
CVS HEALTH CORPORATION	-29.08%	70.89B
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY	+3.59%	28.32B
LABORATORY CORPORATION OF AMERICA HOLDINGS	-7.08%	17.73B
FRESENIUS SE & CO. KGAA	+2.07%	17.43B
QUEST DIAGNOSTICS INCORPORATED	+0.93%	15.64B
REDE D'OR SÃO LUIZ S.A.	+6.68%	13.46B
FRESENIUS MEDICAL CARE AG	+8.40%	12.82B
NATERA, INC.	+68.45%	12.69B

Other Healthcare Facilities & Services